Terns Pharmaceuticals Files 2025 Proxy Statement
Ticker: TERN · Form: DEF 14A · Filed: Apr 29, 2025 · CIK: 1831363
Sentiment: neutral
Topics: proxy-statement, governance, annual-meeting
TL;DR
Terns Pharma filed its proxy statement for the June 11 meeting - shareholders vote on directors & pay.
AI Summary
Terns Pharmaceuticals, Inc. filed its definitive proxy statement (DEF 14A) on April 29, 2025, for its annual meeting scheduled for June 11, 2025. The filing outlines the company's governance and matters to be voted on by shareholders, including the election of directors and executive compensation.
Why It Matters
This filing provides shareholders with crucial information regarding company leadership and how their votes will influence corporate decisions, impacting the company's strategic direction and shareholder value.
Risk Assessment
Risk Level: low — This is a routine annual filing (DEF 14A) and does not contain new material events or financial disclosures that would inherently increase risk.
Key Players & Entities
- Terns Pharmaceuticals, Inc. (company) — Registrant
- 0000950170-25-060138 (filing_id) — Accession Number
- 20250429 (date) — Filing Date
- 20250611 (date) — Meeting Date
FAQ
What is the purpose of a DEF 14A filing?
A DEF 14A filing, or definitive proxy statement, is used by companies to solicit shareholder votes on important corporate matters, such as the election of directors, executive compensation, and other proposals, typically before an annual or special meeting.
When is the Terns Pharmaceuticals, Inc. annual meeting scheduled?
The annual meeting for Terns Pharmaceuticals, Inc. is scheduled for June 11, 2025.
What is the filing date of this DEF 14A statement?
This definitive proxy statement was filed with the SEC on April 29, 2025.
What is the Central Index Key (CIK) for Terns Pharmaceuticals, Inc.?
The Central Index Key (CIK) for Terns Pharmaceuticals, Inc. is 0001831363.
What is the Standard Industrial Classification (SIC) code for Terns Pharmaceuticals, Inc.?
The Standard Industrial Classification (SIC) code for Terns Pharmaceuticals, Inc. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on April 29, 2025 regarding Terns Pharmaceuticals, Inc. (TERN).